Annual Report 2017

Organization

• President:
  Hitoshi Nakagama
  
  
  • Director:
    Atsushi Ochiai
    
    
  • Group for Clinical Research
    
    

    • Division of Experimental Therapeutics
      

  • Group for Translational Research
    
    

    • Division of Biomarker Discovery
      
      
    • Division of Translational Genomics
      
      
    • Division of Cancer Immunology
      
    • Division of Clinical Pharmacology and Translational Research
      
    • Division of Innovative Pathology and Laboratory Medicine
      

  • Group for Innovative Cancer Treatment
    
    

    • Division of Pathology
      
      
    • Divison of Developmental Therapeutics
      
      
    • Division of Cancer Immunotherapy
      
    • Division of Psycho-Oncology
      
    • Division of Supportive Care Research
      

  • Group for Innovative Diagnostic and Therapeutic Device
    
    

    • Division of Functional Imaging
      
    • Division of Radiation Oncology and Particle Therapy
      
    • Division of BNCT Medical Research
      
    • Division of Science and Technology for Endoscopy
      
    • Division of Surgical Technology
      

  • • Section of Experimental Animals
      
      
    • Section of Support of Animal Experimentation